全文获取类型
收费全文 | 24002篇 |
免费 | 2212篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 193篇 |
儿科学 | 789篇 |
妇产科学 | 730篇 |
基础医学 | 3555篇 |
口腔科学 | 546篇 |
临床医学 | 2854篇 |
内科学 | 5087篇 |
皮肤病学 | 496篇 |
神经病学 | 2539篇 |
特种医学 | 729篇 |
外科学 | 2267篇 |
综合类 | 295篇 |
一般理论 | 16篇 |
预防医学 | 2320篇 |
眼科学 | 358篇 |
药学 | 1498篇 |
中国医学 | 15篇 |
肿瘤学 | 1968篇 |
出版年
2023年 | 131篇 |
2022年 | 195篇 |
2021年 | 415篇 |
2020年 | 390篇 |
2019年 | 475篇 |
2018年 | 486篇 |
2017年 | 437篇 |
2016年 | 505篇 |
2015年 | 629篇 |
2014年 | 790篇 |
2013年 | 1085篇 |
2012年 | 1590篇 |
2011年 | 1563篇 |
2010年 | 922篇 |
2009年 | 816篇 |
2008年 | 1421篇 |
2007年 | 1425篇 |
2006年 | 1349篇 |
2005年 | 1321篇 |
2004年 | 1201篇 |
2003年 | 1086篇 |
2002年 | 979篇 |
2001年 | 423篇 |
2000年 | 437篇 |
1999年 | 404篇 |
1998年 | 288篇 |
1997年 | 255篇 |
1996年 | 217篇 |
1995年 | 186篇 |
1994年 | 158篇 |
1993年 | 157篇 |
1992年 | 294篇 |
1991年 | 314篇 |
1990年 | 268篇 |
1989年 | 256篇 |
1988年 | 228篇 |
1987年 | 241篇 |
1986年 | 251篇 |
1985年 | 241篇 |
1984年 | 187篇 |
1983年 | 176篇 |
1982年 | 123篇 |
1981年 | 105篇 |
1980年 | 112篇 |
1979年 | 176篇 |
1978年 | 117篇 |
1977年 | 113篇 |
1975年 | 108篇 |
1974年 | 115篇 |
1973年 | 107篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
ABSTRACTA monocausal bacteriological understanding of infectious disease orients tuberculosis control efforts towards antimicrobial interventions. A bias towards technological solutions can leave multistranded public health and social interventions largely neglected. In the context of globalising biomedical approaches to infectious disease control, this ethnography-inspired review article reflects upon the implementation of rapid diagnostic technology in low- and middle-income countries. Fieldwork observations in Vietnam provided a stimulus for a critical review of the global rollout of tuberculosis diagnostic technology. To address local needs in tuberculosis control, health managers in resource-poor settings are readily cooperating with international donors to deploy novel diagnostic technologies throughout national tuberculosis programme facilities. Increasing investment in new diagnostic technologies is predicated on the supposition that these interventions will ameliorate disease outcomes. However, suboptimal treatment control persists even when accurate diagnostic technologies are available, suggesting that promotion of singular technological solutions can distract from addressing systemic change, without which disease susceptibility, propagation of infection, detection gaps, diagnostic delays, and treatment shortfalls persist. 相似文献
5.
Christos Loizou Göran Laurell Andreas Arvidsson David Lindquist Karin Nylander Katarina Olofsson 《Acta oto-laryngologica》2015,135(10):1058-1064
Conclusion: Recurrent respiratory papillomatosis (RRP) patients with high surgical treatment frequency (≥ 1/year, HF) were significantly younger and had a more widespread laryngeal disease compared to a low frequency treated group (< 1 treatment/year, LF). This study confirms the existence of a clinical RRP group, not primarily related to HPV sub-type, but more care-intensive and in need of more vigilant follow-up. Objectives: RRP is associated with high morbidity due to its influence on breathing and voice. The purpose of this study was to characterize RRP patients in northern Sweden and investigate possible predictor factors affecting therapeutic needs. Method: Patients from the regional referral area (northern Sweden) were categorized for age, disease duration, juvenile or adult onset, profile of disease development, number of surgical sessions in relation to disease duration, laryngeal deposition of papilloma, gender, and HPV sub-types, in order to identify patients with increased need for frequent surgical treatment. Results: The median age of the RRP patients (n = 48) was 44.5 years; 34 (71%) were males and 14 (29%) females, most were infected with HPV 6. Patients with high surgical treatment frequency/year were significantly younger and showed more widespread papillomatous vegetation in the larynx, compared to the low frequency treated group. 相似文献
6.
Susan C. Fox Jane A. May Natalia Dovlatova Jackie R. Glenn Andrew Johnson Ann E. White 《Platelets》2019,30(3):290-295
Measurement of P-selectin on activated platelets as a means of measuring platelet function utilizing the technology described here has the advantage of not requiring immediate access to specialist equipment and expertise. Blood samples are activated, fixed, stored, and transported to a central laboratory for flow cytometric analysis. Here we have compared P-selectin with other more traditional approaches to measuring platelet function in blood and/or platelet-rich plasma (PRP) from patients with acute coronary syndromes on treatment for at least 1 month with either aspirin and clopidogrel or aspirin with prasugrel. The comparators were light transmission aggregometry (LTA), VerifyNow and Multiplate aggregometry (for determining the effects of aspirin) and LTA, VerifyNow and Multiplate together with the BioCytex VASP phosphorylation assay (for the P2Y12 antagonists). The P-selectin Aspirin Test revealed substantial inhibition of platelet function in all but three of 96 patients receiving aspirin with clopidogrel and in none of 51 patients receiving aspirin and prasugrel. The results were very similar to those obtained using LTA. There was only one patient with high residual platelet aggregation and low P-selectin expression. The same patients identified as “non-responders” to aspirin also presented with the highest residual platelet activity as measured using the VerifyNow system, although not quite as well separated from the other values. With the Multiplate test only one of these patients clearly stood out from the others. The results obtained using the P-selectin P2Y12 Test in 102 patients taking aspirin and clopidogrel were similar to the more traditional approaches in that a wide scatter of results was obtained. Generally, high values seen with the P-selectin P2Y12 Test were also high with the LTA, VerifyNow, Multiplate, and BioCytex VASP P2Y12 Tests. Similarly, low residual platelet function using the P2Y12 test was seen irrespective of the testing procedure used. However, there were differences in some patients. Prasugrel was always more effective than clopidogrel in inhibiting platelet function with none of 56 patients (P-selectin and VerifyNow), only 2 of 56 patients (Multiplate) and only 3 of 56 patients (Biocytex VASP) demonstrating high on-treatment residual platelet reactivity (HRPR) defined using previously published cut-off values. The exception was LTA where there were 11 of 56 patients with HRPR. It remains to be seen which experimental approach provides the most useful information regarding outcomes after adjusting therapies in treated patients. 相似文献
7.
8.
9.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
10.
Schemm Stefanie A. Schemm Andreas Schwenkhagen Anneliese Schaudig Katrin 《Der Gyn?kologe》2019,52(6):463-472
Die Gynäkologie - Frauen im Erwachsenenalter mit einem angeborenen Herzfehler (EMAH) werden in Zukunft aufgrund des medizinischen Fortschritts eine immer größere Patientinnengruppe... 相似文献